Lesvi Lab Azithromycin Powder For Oral Suspension 200mg/5ml
Product details
Registration number: SIN14141P
Classification: Prescription Only
Active ingredients: AZITHROMYCIN DIHYDRATE 209.62 mg/5 mg EQV AZITHROMYCIN ANHYDROUS
Strength: 200 mg/5 ml
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Registrant: ZIWELL MEDICAL (S) PTE LTD
ATC code: J01FA10
HSA approval date: 30 April 2012
Manufacturer(s): Neuraxpharm Pharmaceuticals, SL
Manufacturing country/countries: SPAIN
What are the HSA registration number and classification for Lesvi Lab Azithromycin Powder For Oral Suspension 200mg/5ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14141P
Classification: Prescription Only
What active ingredients and strength are recorded for Lesvi Lab Azithromycin Powder For Oral Suspension 200mg/5ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: AZITHROMYCIN DIHYDRATE 209.62 mg/5 mg EQV AZITHROMYCIN ANHYDROUS
Strength: 200 mg/5 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Lesvi Lab Azithromycin Powder For Oral Suspension 200mg/5ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Who is the recorded registrant for Lesvi Lab Azithromycin Powder For Oral Suspension 200mg/5ml?
According to the HSA dataset updated 7 August 2026:
Registrant: ZIWELL MEDICAL (S) PTE LTD
Which manufacturers and countries are listed for Lesvi Lab Azithromycin Powder For Oral Suspension 200mg/5ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Neuraxpharm Pharmaceuticals, SL
Manufacturing country/countries: SPAIN
Where can I look up Lesvi Lab Azithromycin Powder For Oral Suspension 200mg/5ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14141P or the exact product name Lesvi Lab Azithromycin Powder For Oral Suspension 200mg/5ml. The general register link does not preselect this product.
What are the source dates for this Lesvi Lab Azithromycin Powder For Oral Suspension 200mg/5ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Lesvi Lab Azithromycin Powder For Oral Suspension 200mg/5ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14141P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)